• PMS62 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE WRIST AND HAND BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PIH7 ANNUAL HEALTH INSURANCE TREATMENT COST OF CERVICAL CANCER BASED ON ROUTINELY COLLECTED NATIONWIDE REAL-WORLD FINANCING DATA IN HUNGARY

    May 1, 2020, 00:00 AM

  • PMU63 EXPLORING THE SYMPTOMATOLOGY OF DEPRESSION AND ITS EFFECT ON HEALTHCARE EXPENDITURES AND QUALITY OF LIFE OF DIABETIC PATIENTS

    May 1, 2020, 00:00 AM

  • PIN27 EVALUATING THE COST-EFFECTIVENESS OF A SEQUENTIAL PNEUMOCOCCAL VACCINATION COMPARED TO SINGLE DOSE VACCINATION STRATEGY FOR ADULTS IN HONG KONG

    May 1, 2020, 00:00 AM

  • PMU50 CHARACTERIZATION AND TRENDS OF MATERNAL MORTALITY IN TWO TERTIARY HOSPITALS IN NIGERIA: WHY DID THEY DIE?

    May 1, 2020, 00:00 AM

  • Gastrointestinal Disorders - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • PCN8 COMPARING PATIENT-RELEVANT ENDPOINT WITH CLINICAL ENDPOINT IN A RARE DISEASE: THE CASE OF METASTATIC MERKEL CELL CARCINOMA TREATED WITH AVELUMAB

    May 1, 2020, 00:00 AM

  • PIN37 INFLUENZA VACCINATION COSTS IN FRENCH HOSPITALS: A DECISION-TREE MODEL.

    May 1, 2020, 00:00 AM

  • PMU31 ABSENTEEISM AND WORK DISABILITY ASSOCIATED WITH PSORIASIS AND PSORIATIC ARTHRITIS IN THE US

    May 1, 2020, 00:00 AM

  • PDB25 COST-EFFECTIVENES OF REAL-WORLD USE OF GLP-1 RECEPTOR AGONISTS VERSUS OTHER GLUCOSE-LOWERING AGENTS IN TYPE 2 DIABETES

    May 1, 2020, 00:00 AM

  • PMH30 PREVALENCE AND FACTORS ASSOCIATED WITH NARCOTIC CONTROLLED SUBSTANCE USE AMONG PEOPLE WITH DEPRESSION AND ANXIETY: NHANES 2015-2016

    May 1, 2020, 00:00 AM

  • PDB61 MULTIVARIATE LOGISTIC REGRESSION APPLIED TO CLINICAL EFFECTIVENESS IN THE DIABETES PREVENTION PROGRAM (DPP)

    May 1, 2020, 00:00 AM

  • Drugs Generics - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • PIH54 PROVISION OF CONTRACEPTIVES AS A MARKER OF POST-PARTUM QUALITY OF CARE AMONG WOMEN ENROLLED IN MEDICAID

    May 1, 2020, 00:00 AM

  • Drugs Generics - Medical Technologies

    May 1, 2020, 00:00 AM

  • PGI34 ESTIMATING HEALTH-STATE UTILITY VALUES IN REFLUX ESOPHAGITIS USING THE EQ-5D-5L

    May 1, 2020, 00:00 AM

  • PDB70 THE PREVALENCE OF MICROALBUMINURIA IN ADOLESCENTS WITH OBESITY IN UNITED STATES USING THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES) DATA 2011-2016

    May 1, 2020, 00:00 AM

  • PDB89 OBESITY PUBLICATION PATTERNS OVER 20 YEARS: WEIGHING DOWN OBESITY DRUG AVAILABILITY?

    May 1, 2020, 00:00 AM

  • PMS66 A NOVEL VISUAL TOOL TO UNDERSTAND THE TREATMENT PATTERNS AMONG TREATMENT-NAÏVE PSORIATIC ARTHRITIS PATIENTS PRESCRIBED BIOLOGICS IN THE US VETERANS HEALTH ADMINISTRATION POPULATION

    May 1, 2020, 00:00 AM

  • PMS77 PILOT INVESTIGATION OF THE QUALITY OF LIFE AND SOCIO-DEMOGRAPHIC FACTORS OF PATIENTS UNDERWENT TOTAL HIP ARTHROPLASTY IN THE PRIVATE HEALTH CARE SECTOR IN HUNGARY

    May 1, 2020, 00:00 AM

  • PMS39 COST-EFFECTIVENESS OF SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS IN BRAZIL

    May 1, 2020, 00:00 AM

  • Injury Trauma - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • Gastrointestinal Disorders - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PIH77 SOCIOECONOMIC INEQUALITY IN HIV PREVENTION AMONGST FEMALE SEX WORKERS: A CROSS-SECTIONAL ANALYSIS OF ORAL PRE-EXPOSURE PROPHYLAXIS IN RURAL KENYA

    May 1, 2020, 00:00 AM

  • PIN86 PSYCHOMETRIC ASSESSMENT OF URDU VERSION OF BRIEF HIV WORLD HEALTH ORGANIZATION QUALITY OF LIFE INSTRUMENT IN PAKISTANI HIV/AIDS PATIENTS

    May 1, 2020, 00:00 AM

  • PMD52 ECONOMIC AND CLINICAL OUTCOMES OF SPINAL FUSION SURGERIES WITH SKIN CLOSURE THROUGH SKIN STAPLES PLUS WATERPROOF WOUND DRESSINGS VERSUS 2-OCTYL CYANOACRYLATE PLUS POLYMER MESH TAPE

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • Diabetes/Endocrine/Metabolic Disorders - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • PIH28 MEASURING THE COST OF PRESSURE ULCERS AMONG US HOSPITAL PATIENTS: A CLUSTERING APPROACH

    May 1, 2020, 00:00 AM

  • PIN23 A MACHINE LEARNING BASED METAMODEL FOR COST-EFFECTIVENESS ANALYSIS OF HEPATITIS C TREATMENT

    May 1, 2020, 00:00 AM

  • PMS92 ECONOMIC AND CLINICAL BURDEN OF SYSTEMIC LUPUS ERYTHEMATOSUS IN LATIN AMERICA

    May 1, 2020, 00:00 AM

  • PDG65 OPIOID USE DISORDER AND HEALTH-RELATED QUALITY OF LIFE

    May 1, 2020, 00:00 AM

  • CC4 COST-EFFECTIVENESS ANALYSIS OF THE STEPPED EXERCISE PROGRAM FOR PATIENTS WITH KNEE OSTEOARTHRITIS (STEP-KOA) TRIAL

    May 1, 2020, 00:00 AM

  • PIH74 EFFECTS OF EXPOSURE TO FIRST-HAND SMOKE, SECOND-HAND SMOKE AND THIRD-HAND SMOKE ON QUALITY OF LIFE IN PREGNANT WOMEN: A NATIONAL-BASED STUDY

    May 1, 2020, 00:00 AM

  • PIN32 COST-UTILITY ANALYSIS OF NEW ANTIVIRAL TREATMENTS FOR NON-GENOTYPE 1 HEPATITIS C VIRUS IN CHINA: A SOCIETAL PERSPECTIVE

    May 1, 2020, 00:00 AM

  • PMD2 HEALTH OUTCOMES ASSOCIATED WITH DIFFERENT TRANSFUSION MODALITIES IN SICKLE CELL DISEASE

    May 1, 2020, 00:00 AM

  • PMS48 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE ANKLE AND FOOT BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PBI4 EVIDENCE REQUIREMENT TRENDS FOR SINGLE ARM STUDY SCENARIOS IN RARE DISEASE AND ONCOLOGY: WHAT ARE THE LESSONS FOR VALUE DEMONSTRATION?

    May 1, 2020, 00:00 AM

  • Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries

    May 1, 2020, 00:00 AM

  • PIH81 UTERUS ENDOMETRIOSIS IN BRAZIL: TREATMENT PATTERNS AND COSTS IN THE PUBLIC HEALTHCARE BRAZILIAN SYSTEM

    May 1, 2020, 00:00 AM

  • PMD7 ONE-YEAR COMPLICATIONS AND REIMBURSEMENT AFTER INTRAMEDULLARY NAIL FIXATION FOR DISTAL FEMUR FRACTURES AMONG THE MEDICARE POPULATION

    May 1, 2020, 00:00 AM

  • PMH29 EXAMINING HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA AND SUBSTANCE ABUSE DISORDER USING REAL WORLD EVIDENCE DATA

    May 1, 2020, 00:00 AM

  • PIH46 COSTS AND OUTCOMES ASSOCIATED TO POTENTIALLY INAPPROPRIATE DRUG PRESCRIBING DETECTED BY ALGORITHM: PRELIMINARY RESULTS FROM THE MAPT STUDY

    May 1, 2020, 00:00 AM

  • PDG62 HEALTH STATE UTILITIES OF PEOPLE WHO USE OPIOIDS REGURLARLY IN NEW SOUTH WALES, VICTORIA AND TASMANIA, AUSTRALIA: ARE THEY RELATED TO DRUG HISTORY AND OPIOID SUBSTITUTION THERAPY?

    May 1, 2020, 00:00 AM

  • PMD42 HEALTHCARE RESOURCE UTILIZATION AFTER TREATMENT WITH CEMENTED TOTAL KNEE ARTHTROPLASTY

    May 1, 2020, 00:00 AM

  • PMS53 EPIDEMIOLOGICAL DISEASE BURDEN OF FEMORAL NECK FRACTURE BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PIN47 COMPARATIVE BUDGET IMPACT ANALYSIS OF PNEUMOCOCCAL VACCINES IN COLOMBIAN IMMUNIZATION PROGRAM

    May 1, 2020, 00:00 AM

  • PMS84 PSYCHOMETRIC ANALYSIS OF THE PEDIATRIC QUALITY OF LIFE GENERIC CORE SCALE AND NEUROMUSCULAR MODULE IN DUCHENNE MUSCULAR DYSTROPHY: IMPLICATIONS FOR DETERMINING PATIENT-PERCEIVED TREATMENT BENEFIT

    May 1, 2020, 00:00 AM

  • PGI15 COST PER REMISSION WITH VEDOLIZUMAB AND USTEKINUMAB FOR THE TREATMENT OF MODRATE TO SEVERELY ACTIVE CROHN'S DISEASE IN BRAZIL: PERSPECTIVE OF THE PRIVATE HEALTHCARE SYSTEM

    May 1, 2020, 00:00 AM

  • PMU54 ANALYSIS OF E-PRESCRIPTION SYSTEM AND AWARENESS OF PHARMACISTS ON REIMBURSEMENT PROGRAM IN UKRAINE

    May 1, 2020, 00:00 AM

  • PGI2 SYSTEMATIC REVIEW AND META-ANALYSIS OF INFLIXIMAB, ADALIMUMAB, GOLIMUMAB, VEDOLIZUMAB, AND TOFACITINIB FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS IN ANTI-TNF-ALPHA-NAIVE PATIENTS

    May 1, 2020, 00:00 AM

  • PMU24 PROPORTIONAL SHORTFALL - AN ALTERNATIVE APPROACH TO QALY ESTIMATION WITHIN ECONOMIC EVALUATION

    May 1, 2020, 00:00 AM

  • Mental Health - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • PIN65 ESTIMATING THE LIFETIME ECONOMIC BURDEN OF STREPTOCOCCUS SUIS AND ITS PRODUCTIVITY IMPACT IN THAILAND

    May 1, 2020, 00:00 AM

  • PIH6 PREFERENCES AND WILLINGNESS TO PAY FOR EARLY DIAGNOSIS OF ENDOMETRIOSIS TO REDUCE THE ADVERSE RISK OUTCOMES: A DISCRETE CHOICE EXPERIMENT

    May 1, 2020, 00:00 AM

  • PDG19 COST-EFFECTIVENESS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENT’S

    May 1, 2020, 00:00 AM

  • PMU18 ECONOMIC EVALUATION OF AN NT-PROBNP-SUPPORTED DIAGNOSTIC STRATEGY AMONG DYSPNEIC PATIENTS SUSPECTED OF ACUTE HEART FAILURE IN THE EMERGENCY DEPARTMENT

    May 1, 2020, 00:00 AM

  • PDB33 THE EFFECT OF DEPRESSION ON HEALTH CARE UTILIZATION AND HEALTH EXPENDITURE IN PATIENTS WITH DIABETES

    May 1, 2020, 00:00 AM

  • PMH6 DERIVING CLINICAL OUTCOME MEASURES FROM EXPRESSION AND SPEECH: RESULTS OF A PROOF OF CONCEPT STUDY

    May 1, 2020, 00:00 AM

  • PMS27 CONCEPTUAL FRAMEWORK FOR ECONOMIC EVALUATION OF KNEE KINESIOGRAPHY FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS

    May 1, 2020, 00:00 AM

  • PMU55 UNDERSTANDING STAKEHOLDER PERSPECTIVES ON DRUG AFFORDABILITY: EVALUATING USE AND APPLICATION IN VALUE-BASED CARE

    May 1, 2020, 00:00 AM

  • PGI38 VOICING MY CHOICE: A QUALITATIVE EVALUATION OF PATIENTS' PERCEIVED USEFULNESS OF A PATIENT-CENTERED OPTION TOOL FOR COLORECTAL CANCER SCREENING IN AN INTERNAL MEDICINE CLINIC

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • Gastrointestinal Disorders - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • PDG74 AVAILABILITY OF FDA-APPROVED SURROGATE MARKERS IN REAL-WORLD DATA

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Health Policy  Regulatory

    May 1, 2020, 00:00 AM

  • PBI13 TRENDS IN LIST PRICES, NET PRICES, AND DISCOUNTS OF SELF-ADMINISTERED TUMOR NECROSIS FACTOR INHIBITORS

    May 1, 2020, 00:00 AM

  • PMS50 EPIDEMIOLOGICAL DISEASE BURDEN OF SCOLIOSIS BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PMH49 PREDICTORS OF TIME TO OUTPATIENT FOLLOW-UP AND COSTS AFTER HOSPITALIZATION AMONG MEDICAID BENEFICIARIES UTILIZING ORAL VERSUS LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN BIPOLAR DISORDER OR SCHIZOPHRENIA

    May 1, 2020, 00:00 AM

  • PMD6 INFECTIONS AND REOPERATIONS AFTER HAMMERTOE SURGERY IN OLDER PATIENTS

    May 1, 2020, 00:00 AM

  • PMU68 ASSESSING THE EFFECT OF THE DIETICIAN PROGRAM FOR MEMBERS WITH CHRONIC DISEASES AT BLUE CROSS BLUE SHIELD OF LOUISIANA

    May 1, 2020, 00:00 AM

  • PDB52 IMPACT OF USING DIFFERENT TYPES OF HBA1C PROGRESSION IN THE IQVIA CORE DIABETES MODEL

    May 1, 2020, 00:00 AM

  • PIN58 HUMAN PAPILLOMAVIRUS VACCINE:ADVERSE EVENTS REPORTED TO THE US VACCINE ADVERSE EVENTS REPORTING SYSTEM (2010-2019)

    May 1, 2020, 00:00 AM

  • PMS17 COST EFFECTIVENESS ANALYSIS OF UPADACITINIB AND METHOTREXATE FOR PATIENTS WITH METHOTREXATE-RESISTANT RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00 AM

  • The EQ-5D-5L Value Set for England: Findings of a Quality Assurance Program

    May 1, 2020, 00:00 AM

  • PDG72 ASSOCIATION BETWEEN THE INABILITY TO OBTAIN NECESSARY PRESCRIPTION MEDICAL CARE AND FUTURE HEALTHCARE EXPENDITURES IN THE MEDICAL EXPENDITURE PANEL (2015-2017)

    May 1, 2020, 00:00 AM

  • PIN77 ASSESSING THE REAL-WORLD INPATIENT TREATMENT PARADIGM FOR RECURRENT CLOSTRIDIUM DIFFICILE

    May 1, 2020, 00:00 AM

  • PIH14 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADDING ETONORGESTREL CONTRACEPTIVE IMPLANT TO INDIA'S CURRENT FAMILY WELFARE PROGRAM

    May 1, 2020, 00:00 AM

  • PMD39 EFFICIENCY AND ECONOMIC ANALYSIS OF OPTICAL BIOMETERS: EXPERIENCE FROM A PRIVATE EYE MEDICAL CENTER IN THE UNITED STATES OF AMERICA

    May 1, 2020, 00:00 AM

  • Author's Reply

    May 1, 2020, 00:00 AM

  • PMS49 EPIDEMIOLOGICAL DISEASE BURDEN OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PMU22 A SYSTEMATIC REVIEW FOR BURDEN OF DISEASE STUDIES IN CHINA: ARE THERE STILL UNMET NEEDS?

    May 1, 2020, 00:00 AM

  • PDB22 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) AND SF-6D UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUAL ...

    May 1, 2020, 00:00 AM

  • Drugs Generics - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • PMH72 HEALTHCARE RESOURCE UTILIZATION (HRU) ASSOCIATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) COMPARED WITH OTHER TREATMENTS IN PUBLICLY INSURED PATIENTS WITH OPIOID USE DISORDER (OUD)

    May 1, 2020, 00:00 AM

  • PIH2 EFFICACY AND SAFETY OF MIDAZOLAM ORAL SOLUTION FOR SEDATIVE-HYPNOSIS AND ANTI-ANXIETY IN CHILDREN: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PIN3 RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A U.S. OBSERVATIONAL COHORT STUDY

    May 1, 2020, 00:00 AM

  • Diabetes/Endocrine/Metabolic Disorders - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • PMD9 COST-EFFECTIVENESS OF MOISTURE WICKING FABRIC IN THE TREATMENT OF INTERTRIGO COMPARED TO STANDARD OF CARE (SOC) IN A BRITISH CARE HOME SETTING USING A MARKOV DECISION MODEL

    May 1, 2020, 00:00 AM

  • PDB74 EPIDEMIOLOGICAL DISEASE BURDEN OF NON-INSULIN-DEPENDENT DIABETES WITH MULTIPLE COMPLICATIONS BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • Mental Health - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Health Service Delivery Process of Care

    May 1, 2020, 00:00 AM

  • PMS13 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH POLYMYALGIA RHEUMATICA IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PGI39 INFLAMMATORY BOWEL DISEASE PATIENT'S TREATMENT PREFERENCES - USING QUALITATIVE PATIENT SURVEY DATA TO DEVELOP A DISCRETE CHOICE EXPERIMENT

    May 1, 2020, 00:00 AM

  • PDB43 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES PREVENTION PROGRAM (DPP): QUALITY OF WELL BEING (QWB) VERSUS SF-6D INSTRUMENTS

    May 1, 2020, 00:00 AM

  • PDB98 THE IMPACT OF SEVERE VASOMOTOR SYMPTOMS ON WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT: FINDINGS FROM A US REAL WORLD SURVEY

    May 1, 2020, 00:00 AM

  • PMH5 EFFICACY AND SAFETY OF LURASIDONE AND OTHER ATYPICAL ANTIPSYCHOTIC AGENTS FOR BIPOLAR DEPRESSION: UPDATED SYSTEMATIC REVIEW AND META-ANALYSES

    May 1, 2020, 00:00 AM

  • PMS44 THE ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND COMORBIDITIES IN U.S OSTEOARTHRITIS PATIENTS: FINDINGS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2007 TO 2010

    May 1, 2020, 00:00 AM

  • PMU64 IS THERE AN ASSOCIATION BETWEEN NON-COMMUNICABLE DISEASE MORTALITY AND CORRUPTION INDEXES? A GLOBAL PERSPECTIVE

    May 1, 2020, 00:00 AM

  • PCN6 REAL-WORLD CLINICAL OUTCOMES AND HOSPITAL COSTS ASSOCIATED WITH POWERED STAPLER IN VIDEO-ASSISTED THORACIC SURGERY LOBECTOMY FOR LUNG CANCER IN A CHINESE TERITARY CARE HOSPITAL

    May 1, 2020, 00:00 AM

  • PIN50 NON-SEXUAL RISK BEHAVIORS ARE ASSOCIATED WITH INCREASED ODDS OF HIV TESTING: RESULTS FROM THE 2017 BRFSS

    May 1, 2020, 00:00 AM

  • PIN88 THE EXAMINATION OF THE PARENTAL DECISION ON CHOOSING VARICELLA VACCINATION

    May 1, 2020, 00:00 AM

  • PMU2 DEVELOPMENT AND USE OF SIMULATION-BASED TOOL INFORMING CLINICAL AND MARKET ACCESS STRATEGY

    May 1, 2020, 00:00 AM

  • PDB30 HOSPITALIZATIONS AND COMORBIDITIES IN CHRONIC GOUT WITH AND WITHOUT TOPHUS: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00 AM

  • PMH64 INPATIENT PRESCRIBING PATTERNS OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS AND THEIR ORAL OR SHORT-ACTING INJECTABLE FORMULATIONS

    May 1, 2020, 00:00 AM

  • PCV70 CLINICAL DECISION SUPPORT INTERVENTIONS FOR PROMOTING GUIDELINE-CONCORDANT ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: TARGETED LITERATURE REVIEW OF KEY FEATURES AND GAPS IN EVIDENCE

    May 1, 2020, 00:00 AM

  • Drugs Generics - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PMS86 QUALITY OF LIFE AND WORK PRODUCTIVITY BY PAIN SEVERITY AMONG INDIVIDUALS WITH OSTEOARTHRITIS IN THE UNITED STATES: ANALYSIS OF A CROSS-SECTIONAL SURVEY

    May 1, 2020, 00:00 AM

  • PDG11 COST MINIMIZATION ANALYSIS OF TRASTUZUMAB SUBCUTANEOUS VERSUS INTRAVENOUS IN TREATMENT OF HER2-POSITIVE EARLY OR METASTATIC BREAST CANCER IN VIETNAM

    May 1, 2020, 00:00 AM

  • PIT7 DOES INTRAARTICULAR INVOLVEMENT INCREASE THE RISK OF COMPLICATIONS AFTER FRACTURE REPAIR SURGERY?

    May 1, 2020, 00:00 AM

  • PMD19 SYSTEMATIC LITERATURE REVIEW TO IDENTIFY THE CURRENT STATE OF KNOWLEDGE REGARDING HOME INFUSION VS MEDICAL-SETTING INFUSION

    May 1, 2020, 00:00 AM

  • PMS26 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE KNEE AND LOWER LEG BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00 AM

  • PMS9 PLACEBO EFFECT IN KNEE OSTEOARTHRITIS: A TARGETED LITERATURE REVIEW ON THE CHALLENGES, HYPOTHESES, AND POTENTIAL SOLUTIONS

    May 1, 2020, 00:00 AM

  • Objective Estimates of Direct-Medical Costs Among Persons Aged 3 to 38 Years With and Without Research-Defined Autism Spectrum Disorder Ascertained During Childhood: A Population-Based Birth-Cohort Study

    May 1, 2020, 00:00 AM

  • PMS28 COST-UTILITY ANALYSIS OF TREATMENT OPTIONS AFTER INITIAL TUMOR NECROSIS FACTOR INHIBITOR THERAPY FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00 AM

  • PDB51 IMPACT OF SENSOR AUGMENTED PUMP (SAP) IN TYPE 1 DIABETES MELLITUS (DMT1) PATIENTS IN COLOMBIA

    May 1, 2020, 00:00 AM

  • PIH55 TIME TRENDS AND FACTORS PREDICTING ANTICHOLINERGIC MEDICATION PRESCRIBING TO OLDER ADULTS IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PMS31 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE ANKLE AND FOOT BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00 AM

  • PMU36 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT IN JAPAN

    May 1, 2020, 00:00 AM

  • PMS74 THE EXAMINATION OF THE RELATIONSHIP BETWEEN BALANCE AND POSTURAL MUSCLES AMONG ELEMENTARY SCHOOL CHILDREN

    May 1, 2020, 00:00 AM

  • PDG39 CHALLENGE OR OPPORTUNITY? THE EXPANSION OF DRUG VOLUME-BASED PROCUREMENT IN CHINA

    May 1, 2020, 00:00 AM

  • PCV73 COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS WITH MULTICRITERIA DECISION ANALYSIS

    May 1, 2020, 00:00 AM

  • PIH9 BUDGET IMPACT ANALYSIS VS. COST EFFECTIVENESS ANALYSIS - HORMONAL CONTRACEPTIVES AS AN ILLUSTRATIVE CASE

    May 1, 2020, 00:00 AM

  • PMH21 PROVIDING THE DEPRESSION CARE FOR PEOPLE WITH CANCER PROGRAM TO PROSTATE CANCER PATIENTS IN THE UNITED STATES: A COST-EFFECTIVENESS ANALYSES

    May 1, 2020, 00:00 AM

  • PIN22 MORTALITY, MORBIDITY AND BURDEN OF HOSPITALIZATIONS IN INFLUENZA PATIENTS WITH LOW AND HIGH COMORBIDITY INDEX: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00 AM

  • A Systematic Review of Economic Evaluations Reporting the Cost-Effectiveness of Spinal Cord Stimulation

    May 1, 2020, 00:00 AM

  • PMU23 QUANTIFYING THE COSTS OF OBESITY-RELATED COMPLICATIONS IN THE UNITED STATES: A RETROSPECTIVE DATABASE STUDY

    May 1, 2020, 00:00 AM

  • PDB27 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUALITY ADJUST ...

    May 1, 2020, 00:00 AM

  • PMS54 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • Individual's Health - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • Mental Health - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • Musculoskeletal Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00 AM

  • Diabetes/Endocrine/Metabolic Disorders - Methodological Statistical Research

    May 1, 2020, 00:00 AM

  • Medical Devices - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • PMU4 EVIDENCE FOR THE USABILITY OF THE E-TSQM

    May 1, 2020, 00:00 AM

  • PGI41 SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN PATIENTS WITH ULCERATIVE COLITIS

    May 1, 2020, 00:00 AM

  • PMH20 ECONOMIC BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): A GLOBAL SYSTEMATIC REVIEW

    May 1, 2020, 00:00 AM

  • PMU48 EFFECT OF MOBILE HEALTH INTERVENTIONS ON MATERNAL AND CHILD HEALTH: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2020, 00:00 AM

  • PMS2 RETROSPECTIVE ANALYSIS TO DETERMINE THE INCREASED RISK OF DEVELOPING OSTEOPOROSIS IN PATIENTS DIAGNOSED WITH DEPRESSION AND/OR PRESCRIBED ANTIDEPRESSANTS

    May 1, 2020, 00:00 AM

  • PIH13 IMPACT OF INCREASED UTILIZATION OF LONG-ACTING REVERSABLE CONTRACEPTIVE METHODS AMONG YOUNG WOMEN ON COST AND UNINTENDED PREGNANCIES (UP) IN THE UNITED STATES (US)

    May 1, 2020, 00:00 AM

  • PMD41 ASSESSING THE CLINICAL EFFECTIVENESS OF POLYSOMNOGRAPHY AND PORTABLE DEVICE (LEVEL III) FOR THE DIAGNOSIS OF SLEEP DISORDER BREATHING: SYSTEMATIC REVIEW META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PDB41 HOW MUCH DOES THERAPEUTIC INERTIA IN TYPE 2 DIABETES COST THE UK? A MODELING EVALUATION OF ECONOMIC BURDEN

    May 1, 2020, 00:00 AM

  • PMS36 THE ECONOMIC BURDEN OF FIBROMYALGIA IN CHINA

    May 1, 2020, 00:00 AM

  • PIH16 ESTIMATING THE VALUE OF NURSING TIME TO REDUCE COSTS AND INCREASE QUALITY OF PRESSURE INJURY PREVENTION IN NURSING HOMES: A COST-EFFECTIVENESS ANALYSIS OF THE TEAM-UP CLINICAL TRIAL

    May 1, 2020, 00:00 AM

  • PDB105 STUDY OF INTERRUPTED TIME SERIES TO DETERMINE THE EFFECT OF POLICY IN PATIENTS WITH T2DM USING SGLT2 IN TWO HEALTH MAINTENANCE ORGANIZATION IN COLOMBIA

    May 1, 2020, 00:00 AM

  • PCV54 AGE-SPECIFIC EXAMINATION OF EARLY CEREBROVASCULAR MORTALITY: 1990-2014

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • Copyright/Subscription

    May 1, 2020, 00:00 AM

  • PBI43 REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2020, 00:00 AM

  • PMD40 FEMTOSECOND LASER ASSISTED CATARACT SURGERY: A REVIEW OF ITS EFFICIENCY COMPARED TO MANUAL CATARACT SURGERY

    May 1, 2020, 00:00 AM

  • PDG16 A REVIEW OF THE EVIDENCE ON THE NET MONETARY BENEFIT OF SMOKING CESSATION INTERVENTIONS

    May 1, 2020, 00:00 AM

  • PIN64 INFLUENZA VACCINATION STATUS IN AMERICAN INDIANS AND ALASKA NATIVES FOR THE 2018‑2019 INFLUENZA SEASON IN TRINETX ELECTRONIC MEDICAL RECORD DATA

    May 1, 2020, 00:00 AM

  • PIH78 RASCH ANALYSIS OF THE STUDENT REFRACTIVE ERROR AND EYEGLASS QUESTIONNAIRE-R IN MYOPIC SCHOOL-AGED CHILDREN/CHILDREN AND YOUNG PEOPLE IN LONDON

    May 1, 2020, 00:00 AM

  • PCV61 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN REDUCING THE PROBABILITY OF PREMATURE DEATH DUE TO CARDIOVASCULAR EVENTS IN THE COLOMBIAN CARIBBEAN REGION

    May 1, 2020, 00:00 AM

  • PBI41 LONGITUDINAL EVALUATION OF PRODUCT UTILIZATION AND CHARACTERISTICS AMONG PATIENTS TREATED WITH BIOLOGIC ANTI-INFLAMMATORY AGENTS: A STUDY BY THE BIOLOGICS AND BIOSIMILARS COLLECTIVE INTELLIGENCE CONSORTIUM

    May 1, 2020, 00:00 AM

  • Musculoskeletal Disorders - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • PIH73 INFLUENCE OF MATERNAL MINDFULNESS TRAINING DURING PREGNANCY ON EXECUTIVE ABILITIES IN PRESCHOOL CHILDREN

    May 1, 2020, 00:00 AM

  • PCV83 COMPARISON OF TREATMENT ADHERENCE AND PERSISTENCE WITH EDOXABAN VERSUS APIXABAN, DABIGATRAN, RIVAROXABAN, AND VITAMIN K ANTAGONIST IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN GERMANY: A PROPENSITY MATCHED COHORT STUDY

    May 1, 2020, 00:00 AM

  • PIH68 HEALTH-RELATED QUALITY OF LIFE MEASUREMENTS IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00 AM

  • PIH17 ECONOMIC IMPACT OF VAGUS NERVE STIMULATION THERAPY IN PEDIATRIC PATIENTS WITH DRUG-RESISTANT EPILEPSY

    May 1, 2020, 00:00 AM

  • Diabetes/Endocrine/Metabolic Disorders - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • Cardiovascular Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00 AM

  • PCV59 EPIDEMIOLOGICAL DISEASE BURDEN OF ACUTE MYOCARDIAL INFARCTION BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PCN11 REAL-WORLD TREATMENT PATTERNS IN RESECTABLE (STAGE I-IIIA) NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR)

    May 1, 2020, 00:00 AM

  • PDB38 BURDEN OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR (CV) RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): AN ANALYSIS OF A US HEALTH INSURANCE DATABASE

    May 1, 2020, 00:00 AM

  • PIH39 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE AND PASSIVE SMOKE EXPOSURE IN PREGNANCY: EVIDENCE FROM A NATIONAL STUDY

    May 1, 2020, 00:00 AM

  • PDG31 THE PRICING AND SPENDING TRENDS OF ULTRA-EXPENSIVE DRUGS IN MEDICARE PART D PROGRAM

    May 1, 2020, 00:00 AM

  • PMH25 CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER CONTINUING, SWITCHING, OR DISCONTINUING THERAPY IN A REAL-WORLD SETTING

    May 1, 2020, 00:00 AM

  • PIN44 SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL: A COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00 AM

  • PBI26 RAPID REVIEW OF TRASTUZUMAB BIOSIMILARS COMPARED TO REFERENCE TRASTUZUMAB FOR BREAST CANCER TREATMENT IN NAIVE PATIENTS

    May 1, 2020, 00:00 AM

  • PBI9 BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENTS

    May 1, 2020, 00:00 AM

  • PMS87 PROGRESSIVE SUBAQUAL TRAINING 3 MONTHS FOLLOW-UP IN FALL PREVENTION OF OSTEOPOROTIC PATIENT

    May 1, 2020, 00:00 AM

  • PIT6 DISCRIMINATIVE ABILITY OF NEW INJURY SEVERITY SCORE TO PREDICT OUTCOMES AFTER FRACTURE REPAIRED SURGERY

    May 1, 2020, 00:00 AM

  • PIH3 ANGIOTENSIN I CONVERTING ENZYME INHIBITORS REDUCE RISK OF PNEUMONIA IN HOSPITALIZED ELDERLY PATIENTS

    May 1, 2020, 00:00 AM

  • Individual's Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00 AM

  • PGI7 EVALUATION OF LIVER OUTCOMES RELATIVE TO USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN REAL-WORLD POPULATIONS DIAGNOSED WITH TYPE II DIABETES (T2DM) AND NASH/NAFLD OR AT RISK OF NASH

    May 1, 2020, 00:00 AM

  • PMH32 PERCEPTION, PREVALENCE AND FACTORS ASSOCIATED TO SCHOOL BULLYING IN YOUNG PEOPLE FROM A POPULATION AFFILIATED IN A COLOMBIAN HEALTH SUBSIDIZED INSURANCE COMPANY IN 2018.

    May 1, 2020, 00:00 AM

  • PIN42 COMPARISON OF ECONOMIC BURDEN AND RISK OF HOSPITALIZATION AMONG HIV PATIENTS WITH AND WITHOUT HEPATITIS B COINFECTION IN THE VETERANS HEALTH ADMINISTRATION POPULATION

    May 1, 2020, 00:00 AM

  • PMH71 VALUE-BASED HEALTHCARE: CAN ARTIFICIAL INTELLIGENCE IMPROVE THE MENTAL HEALTH WITH BRAZILIAN DATA?

    May 1, 2020, 00:00 AM

  • PBI16 COST ANALYSIS OF TWO TREATMENTS BY INFLIXIMAB (ORIGINATOR AND BIOSIMILAR) FOR PATIENTS WITH RHUMATOÏD ARTHRITIS (RA) OR INFLAMMATORY BOWEL DISEASE (IBD) IN A GROUP OF FRENCH PUBLIC HOSPITALS (UNIHA)

    May 1, 2020, 00:00 AM

  • PDG61 TYPES OF ENDPOINTS OF NEW MOLECULAR ENTITIES APPROVED BY THE FDA: THE INCREASING IMPORTANCE OF PATIENT-REPORTED OUTCOMES

    May 1, 2020, 00:00 AM

  • PCV72 DIFFERENTIAL USE OF TRANSCATHETER AORTIC VALVE IMPLANTS (TAVI). PERSONALIZATION STUDY

    May 1, 2020, 00:00 AM

  • PDG71 DOES LIPID LOWERING THERAPY UP-TITRATION IN OLDER ADULTS IMPACT ADHERENCE?

    May 1, 2020, 00:00 AM

  • PDB56 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

    May 1, 2020, 00:00 AM

  • Injury Trauma - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • PMS76 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS OF KNEE OSTEOARTHRITIS IN QUETTA, PAKISTAN

    May 1, 2020, 00:00 AM

  • PDG18 DIFFERENCES IN RESOURCE UTILIZATION AND COSTS BETWEEN NARCOTIC USERS AND NON-NARCOTIC USERS FROM THE 2017 MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2020, 00:00 AM

  • PMD14 PREVENTION VERSUS TREATMENT OF VENOUS ULCERS IN BRAZILIAN NATIONAL HEALTH SYSTEM: HOW MUCH COULD BE SAVED?

    May 1, 2020, 00:00 AM

  • PIN26 ECONOMIC IMPACT IN DOMINICAN REPUBLIC SENASA OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) VERSUS NO VACCINATION IN OLDER ADULTS

    May 1, 2020, 00:00 AM

  • PIH23 A CLINICAL AND ECONOMIC ANALYSIS OF THE SINGLE-DOSE VERSUS MULTIPLE-DOSE APPROACHES OF SURFACTANT USE IN MECONIUM ASPIRATION SYNDROME IN NEONATAL INTENSIVE CARE UNITS IN QATAR

    May 1, 2020, 00:00 AM

  • PCV66 GUIDELINE-DIRECTED MEDICAL THERAPY AMONG HEART FAILURE PATIENTS FACILITATED BY NATURAL LANGUAGE PROCESSING OF AMBULATORY ELECTRONIC HEALTH RECORDS

    May 1, 2020, 00:00 AM

  • PMS46 USE OF HEALTHCARE RESOURCES IN A COHORT OF COLOMBIAN PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS OR TOFACITINIB, 2014–2018

    May 1, 2020, 00:00 AM

  • PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE

    May 1, 2020, 00:00 AM

  • PBI27 TRENDS IN AVERAGE SALES PRICES OF BIOLOGICS REIMBURSED BY THE MEDICARE PART B PROGRAM (FIRST QUARTER 2010-FIRST QUARTER 2020)

    May 1, 2020, 00:00 AM

  • PMD4 THE IMPACT OF USING KNOTLESS SUTURE IN CARDIAC SURGERY ON DECREASING DEBRIDEMENT: A REAL WORLD STUDY IN A CHINESE TIER III HOSPITAL

    May 1, 2020, 00:00 AM

  • PIN30 ESTIMATED BUDGET IMPACT OF THE INTRODUCTION OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) IN THE UNITED STATES FOR THE TREATMENT OF HIV INFECTION

    May 1, 2020, 00:00 AM

  • PMS18 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00 AM

  • PMS22 ANNUAL HEALTH INSURANCE TREATMENT COST OF FEMORAL NECK FRACTURE BASED ON ROUTINELY COLLECTED, REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00 AM

  • PDG43 STIMULANT AND NON-STIMULANT USE AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN US AMBULATORY VISITS

    May 1, 2020, 00:00 AM

  • PDG25 UTILIZATION OF PRESCRIPTION OPIOIDS AND BENZODIAZEPINES AMONG ARKANSANS WITH MEDICAL CANNABIS IDENTIFICATION CARDS: A MATCHED CONTROL STUDY

    May 1, 2020, 00:00 AM

  • Infectious Diseases - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • Mental Health - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • PDG35 EFFECT OF THE IMPLEMENTATION ON THE REGULATION OF DIRECT CONTROL OF MEDICINE’S PRICES IN COLOMBIA

    May 1, 2020, 00:00 AM

  • PDB16 A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Epidemiology Public Health

    May 1, 2020, 00:00 AM

  • PDG4 DESCRIPTION OF PRESCRIPTION OPIOID USE AMONG US ADULTS

    May 1, 2020, 00:00 AM

  • PDB49 THE IMPLICATIONS OF SOARING INSULIN COST FOR DIABETES POPULATION ON US PAYERS

    May 1, 2020, 00:00 AM

  • Injury Statistical Research

    May 1, 2020, 00:00 AM

  • PIN75 IMMUNIZATIONS AND INJECTABLE MEDICATIONS: PHARMACISTS' INTEREST, ENGAGEMENT, AND REIMBURSEMENT PATTERNS IN MISSISSIPPI

    May 1, 2020, 00:00 AM

  • PIH75 ASSESSMENT OF THE RATIONALITY OF PRESCRIBING IN ELDERLY INPATIENTS OF A SOUTH INDIAN HOSPITAL USING BEERS 2015 AND STOPP CRITERIA

    May 1, 2020, 00:00 AM

  • PMD29 HOSPITAL VARIATIONS IN THE USE OF ROBOTIC-ASSISTED SURGERIES IN THE U.S. PEDIATRIC POPULATION

    May 1, 2020, 00:00 AM

  • Injury Trauma - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PMH9 ESTIMATED COST-EFFECTIVENESS OF A 12-WEEK TREATMENT COURSE OF THE FIRST FDA-CLEARED PRESCRIPTION DIGITAL THERAPEUTIC FOR PATIENTS WITH OPIOID USE DISORDER

    May 1, 2020, 00:00 AM

  • PMD3 ONE-YEAR COMPLICATIONS AND REIMBURSEMENT AFTER FIXATION WITH PLATING AND SCREWS FOR DISTAL FEMUR FRACTURES AMONG THE MEDICARE POPULATION

    May 1, 2020, 00:00 AM

  • PMS56 EPIDEMIOLOGICAL DISEASE BURDEN OF FRACTURE OF SKULL AND FACIAL BONES BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PMS23 RATE AND REIMBURSEMENT OF 1-LEVEL AND 2+-LEVEL REOPERATIONS IN CERVICAL TOTAL DISC REPLACEMENT AND ANTERIOR CERVICAL DISCECTOMY AND FUSION

    May 1, 2020, 00:00 AM

  • PCV82 DEVELOPMENT AND VALIDATION OF A METHOD TO EXTRACT LEFT VENTRICULAR EJECTION FRACTION DATA FROM EHR PHYSICIAN NOTES

    May 1, 2020, 00:00 AM

  • PDB20 IS HYPOGLYCEMIA EXPENSIVE？

    May 1, 2020, 00:00 AM

  • PCV52 EFFECTIVENESS OF A CARDIOVASCULAR DISEASE PREVENTION PROGRAM IN THE CONTROL OF CARDIOVASCULAR RISK FACTORS IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Health Service Delivery Process of Care

    May 1, 2020, 00:00 AM

  • PIH33 POTENTIALLY INAPPROPRIATE PRESCRIBING OF PROTON-PUMP INHIBITORS AMONG OLDER PATIENTS IN THE U.S.

    May 1, 2020, 00:00 AM

  • Diabetes/Endocrine/Metabolic Disorders - Economic Evaluation

    May 1, 2020, 00:00 AM

  • Alternative Medicine Process of Care

    May 1, 2020, 00:00 AM

  • Multiple Diseases - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PMD21 ROBOTIC-ASSISTED TOTAL HIP REPLACEMENT: A 90-DAY EPISODE OF CARE ANALYSIS

    May 1, 2020, 00:00 AM

  • PMH24 BUDGET IMPACT ANALYSIS OF VORTIOXETINE AND/OR SERTRALINE USE FOR MANAGEMENT OF MAJOR DEPRESSIVE DISORDER IN THE KINGDOM OF SAUDI ARABIA

    May 1, 2020, 00:00 AM

  • PMU27 ASSESSING RELATIONSHIPS AMONG HOSPITALIZATIONS FOR SPINE-RELATED INFECTIONS, DEMOGRAPHICS, COSTS, AND COMORBIDITY DIAGNOSES IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PGI22 ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WIT ...

    May 1, 2020, 00:00 AM

  • PBI7 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF BEVACIZUMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE

    May 1, 2020, 00:00 AM

  • PIN51 FACTORS ASSOCIATED WITH INCREASED RISK OF HERPES ZOSTER AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    May 1, 2020, 00:00 AM

  • PIH25 PRE-TERM LABOR TRANSPORT: UTILIZATION PATTERNS AND COST AMONG WOMEN IN RURAL AND NON-RURAL AREAS

    May 1, 2020, 00:00 AM

  • PIN2 REAL-WORLD EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH DIRECT-ACTING ANTIVIRALS (DAA) IN POPULATIONS WITH FATTY LIVER/NON-ALCOHOLIC STEATOHEPATITIS (FL/NASH), DECOMPENSATED CIRRHOSIS (DCC), HEPATOCELLULAR CARCINOMA (HCC), A ...

    May 1, 2020, 00:00 AM

  • PDB48 THE COMPARISON OF SGLT2 INHIBITORS AND DPP-4 INHIBITORS ON HEALTH CARE EXPENDITURE AND UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2020, 00:00 AM

  • Mental Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00 AM

  • PIN72 NON-PRESCRIPTION SALES OF ANTIMICROBIALS FROM COMMUNITY PHARMACIES AND DETERMINANTS OF RESISTANCE IN LAHORE PAKISTAN

    May 1, 2020, 00:00 AM

  • PMD20 ECONOMIC IMPACT OF SPECIALIZED LABORATORY AUTOMATION ON THE TURNAROUND TIME (TAT) MEAN AND STANDARD DEVIATION

    May 1, 2020, 00:00 AM

  • PMH66 THE BURDEN OF COST TO PATIENTS WITH OPIOID USE DISORDER TREATED WITH MEDICATION ASSISTED THERAPY: A SYSTEMATIC SCOPING REVIEW

    May 1, 2020, 00:00 AM

  • Alternative Medicine Nutrition - Patient-Centered Research

    May 1, 2020, 00:00 AM

  • PDG13 CURRENT PRESCRIPTION PROFILE OF RIBAVIRIN FOR HEPATITIS C IN BRAZIL AND THE BUDGET IMPACT ANALYSIS ON UPDATED RECOMMENDATIONS FOR ITS USE BETWEEN 2020 AND 2024 IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2020, 00:00 AM

  • PDG66 QUALITY OF LIFE AND ADHERENCE OF PATIENTS TO ORAL NEUROLOGY SPECIALTY MEDICATIONS PROVIDED BY A SPECIALTY PHARMACY

    May 1, 2020, 00:00 AM

  • PIH40 INCIDENCE AND BURDEN OF RECURRENT VAGINITIS AMONG COMMERCIALLY INSURED WOMEN IN THE US

    May 1, 2020, 00:00 AM

  • PDB13 ASSOCIATION OF VERAPAMIL THERAPY AND REDUCED HYPOGLYCEMIC EVENTS AMONG MEDICARE PATIENTS WITH NEWLY DIAGNOSED TYPE 1 DIABETES

    May 1, 2020, 00:00 AM

  • PDB44 DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?

    May 1, 2020, 00:00 AM

  • PDG45 LOW-VALUE CARE: THE ASSOCIATION OF ANTIPSYCHOTIC POLYPHARMACY USE TO ECONOMIC BURDEN IN NON-INSTITUTIONALIZED CIVILIAN POPULATION IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PMS4 OUTPATIENT COSTS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH VS WITHOUT COMORBIDITIES

    May 1, 2020, 00:00 AM

  • Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments [Editor's Choice]

    May 1, 2020, 00:00 AM

  • Musculoskeletal Disorders - Medical Technologies

    May 1, 2020, 00:00 AM

  • Individual's Health - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • PGI3 LEAN AND OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) / NON-ALCOHOLIC FATTY LIVER DISEASE (NALFD); COMPARISONS OF POPULATIONS AND DISEASE PROGRESSION

    May 1, 2020, 00:00 AM

  • PIN24 INCIDENCE AND COSTS OF INFLUENZA-RELATED HOSPITALIZATIONS BY COMORBIDITY IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • Medical Devices - Methodological Statistical Research

    May 1, 2020, 00:00 AM

  • PMS94 PREDICTORS OF IMPROVEMENT IN TENDER JOINT COUNTS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN A LARGE, REPRESENTATIVE US-BASED REAL WORLD REGISTRY COHORT

    May 1, 2020, 00:00 AM

  • PCV62 ASSOCIATED FACTORS TO THE CONTROL OF CARDIOVASCULAR RISK IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • PMS16 ANNUAL HEALTH INSURANCE TREATMENT COST OF SCOLIOSIS BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00 AM

  • Cancer - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • PCV67 OPERATIONAL FEASIBILITY OF PHARMACIST GUIDED PERSONALIZED CONSULT SERVICE IN MANDATORY AND OPTIONAL SETTINGS

    May 1, 2020, 00:00 AM

  • PGI24 EPISODE OF CARE COSTS ASSOCIATED WITH MINIMALLY INVASIVE COLON SURGERY: A PROPENSITY-MATCHED ANALYSIS USING MEDICARE AND COMMERCIAL CLAIMS DATA

    May 1, 2020, 00:00 AM

  • PMH51 WHAT ARE THE ATTRIBUTES THAT PSYCHIATRISTS CONSIDER IN THE DECISION TO DISCHARGE ADULTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE BEEN HOSPITALIZED WITH ACTIVE SUICIDAL IDEATION WITH INTENT?

    May 1, 2020, 00:00 AM

  • PCN16 RESECTION FOR RECURRENT BRAIN METASTASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PIN54 MODELLING THE EFFECT OF TARGETED TREATMENT IN A TB OUTBREAK WITH COMPLEX CONTAGION

    May 1, 2020, 00:00 AM

  • PMS33 BUDGET IMPACT ANALYSIS OF KNEE JOINT REPLACEMENT DELAY IN PATIENTS WITH SEVERE KNEE OSTEOARTHRITIS TREATED WITH HYLAN GF-20, LOW MOLECULAR WEIGHT HYALURONATES AND CORTICOSTEROIDS IN COLOMBIA

    May 1, 2020, 00:00 AM

  • PDB57 VALIDATION OF UKPDS OUTCOMES AND TAIWAN DIABETES MODELS ON TAIWAN TYPE 2 DM POPULATION

    May 1, 2020, 00:00 AM

  • Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019

    May 1, 2020, 00:00 AM

  • Individual's Health - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PMS11 MEDICAL RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS IN A COMPREHENSIVE RHEUMATOLOGICAL CENTER IN COLOMBIA

    May 1, 2020, 00:00 AM

  • Biologics/Biosimilars/Regenerative Medicine - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • PDB21 EVALUATION OF THE ONE-YEAR EFFICIENCY OF THE EDUC@DOM TELEMONITORING AND TELE-EDUCATION PROGRAM FOR TYPE 2 DIABETIC PATIENTS

    May 1, 2020, 00:00 AM

  • PDB54 EVALUATING THE IMPACT OF POOR GLYCEMIC CONTROL ASSOCIATED WITH THERAPEUTIC INERTIA ON LIFE EXPECTANCY IN PATIENTS WITH TYPE 2 DIABETES IN THE UK

    May 1, 2020, 00:00 AM

  • PGI11 COMPARISON OF BURDEN OF HOSPITALIZATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) WITH AND WITHOUT COLORECTAL CANCER: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00 AM

  • PGI17 COST EFFECTIVENESS ANALYSIS OF ENDOSCOPIC CAPSULE FOR DIAGNOSIS OF OBSCURE GASTROINTESTINAL BLEEDING IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    May 1, 2020, 00:00 AM

  • PMS81 PRESCRIPTION DRUG COVERAGE TYPE, OUT-OF-POCKET SPENDING, AND COST-RELATED NONADHERENCE AMONG MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00 AM

  • PDB39 COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA

    May 1, 2020, 00:00 AM

  • PIH64 ADJUSTED INDIRECT COMPARISON OF THE MEDICINES USING IN CONTROLLED OVARIAN STIMULATION FOR ASSISTED REPRODUCTIVE TECHNOLOGY

    May 1, 2020, 00:00 AM

  • PCV87 HEART FAILURE RISK FACTORS ANALYSIS ON STABLE CORONARY ARTERY DISEASE PATIENTS IN CHINA

    May 1, 2020, 00:00 AM

  • PIH76 ITCH REPORTED OUTCOME TOOL FOR CAREGIVERS OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE: AN ANALYSIS OF VALIDATION AND SCORING FROM THE ICONIC MARALIXIBAT STUDY

    May 1, 2020, 00:00 AM

  • PBI3 TRANSFUSION-RELATED ABO INCOMPATIBILITY REACTIONS AMONG THE INPATIENT U.S. MEDICARE BENEFICIARIES, AGES 65 AND OLDER, DURING 2007-2018

    May 1, 2020, 00:00 AM

  • PMS67 DIFFERENCES IN HEALTHCARE EXPENDITURE BETWEEN OPIOID AND NON-OPIOID USERS AMONG A NATIONAL SAMPLE OF COMMUNITY-BASED OLDER UNITED STATES ADULTS WITH PAIN, 2015

    May 1, 2020, 00:00 AM

  • PMS12 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH GIANT CELL ARTERITIS IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PMD23 ANALYSIS OF THE COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE REPLACEMENT AS ALTERNATIVE TO SURGICAL AORTIC VALVE REPLACEMENT IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00 AM

  • PMS83 PILOT INVESTIGATION OF THE QUALITY OF LIFE AND SOCIO-DEMOGRAPHIC FACTORS OF PATIENTS UNDERWENT TOTAL HIP ARTHROPLASTY IN THE STATE HEALTH CARE SECTOR IN HUNGARY

    May 1, 2020, 00:00 AM

  • PMH27 ADHD TREATMENT AND DIAGNOSIS AMONG TEENAGE AND COLLEGE-AGED WOMEN

    May 1, 2020, 00:00 AM

  • PDG38 ASSESSMENT OF GENERIC COMPETITION FOR ORPHAN DRUGS MARKETED IN THE US (1993-2019)

    May 1, 2020, 00:00 AM

  • PIN62 PREVALENCE AND FACTORS ASSOCIATED WITH NEVER-VACCINATED CHILDREN AGED 12-59 MONTHS IN ETHIOPIA. A MULTILEVEL ANALYSIS OF THE INDIVIDUAL AND CONTEXTUAL FACTORS

    May 1, 2020, 00:00 AM

  • Medical Devices - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • PDB64 THERAPEUTIC INERTIA IN THE TREAMENT OF PATIENTS WITH TYPE 2 DIABETES IN A CARDIOVASCULAR RISK MANAGEMENT COHORT FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • PIH15 ANNUAL HEALTH INSURANCE TREATMENT COST OF ENDOMETRIOSIS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00 AM

  • PMU46 PSYCHOTROPIC POLYPHARMACY AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS TREATED WITH ANTIDEPRESSANTS IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PCN7 COMPARATIVE EFFECTIVENESS OF GRANULOCYTE COLONY STIMULATING FACTOR UTILIZATION VERSUS CHEMOTHERAPY DOSE REDUCTION ON OVERALL SURVIVAL: A PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2020, 00:00 AM

  • PMH28 ANTIPSYCHOTIC DRUG USE AMONG A US NATIONAL COHORT OF OLDER DEMENTIA PATIENTS USING ACETYLCHOLINESTERASE INHIBITORS

    May 1, 2020, 00:00 AM

  • PIN59 17-YEAR DISEASE REDUCTION PREDICTED BY A TRANSMISSION DYNAMIC MODEL AFTER PNEUMOCOCCAL CONJUGATE VACCINE INTRODUCTION IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PIN12 THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES

    May 1, 2020, 00:00 AM

  • PDB10 EVALUATION OF THE RATE OF PREVENTABLE DIABETES-RELATED HOSPITALIZATIONS IN MEDICAID

    May 1, 2020, 00:00 AM

  • Medical Devices - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PDG44 COPRESCRIBING OF OPIOIDS AND BENZODIAZEPINES IN TEXAS MEDICAID ENROLLEES

    May 1, 2020, 00:00 AM

  • PIH48 DIFFERENTIAL PRESCRIPTION PATTERNS OF DROSPIRENONE-CONTAINING COMBINED ORAL CONTRACEPTIVES IN EUROPE AND NORTH AMERICA - INSIGHTS FROM THE INAS-FOCUS STUDY

    May 1, 2020, 00:00 AM

  • PMS42 HEALTHCARE EXPENDITURE HEALTH-RELATED QUALITY OF LIFE OF MUSCULOSKELETAL PAIN PATIENTS ON OPIOIDS VERSUS NSAIDS

    May 1, 2020, 00:00 AM

  • PIH50 FACTORS AND PATTERNS OF OFF-LABEL PRESCRIBING IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN US. OUTPATIENT SETTINGS OVER A TEN-YEAR PERIOD

    May 1, 2020, 00:00 AM

  • Defining Comparators According to IQWiG’s Efficiency-Frontier Method

    May 1, 2020, 00:00 AM

  • PIN9 ADHERENCE ISSUES AMONG PEOPLE LIVING WITH HIV ON ANTIRETROVIRAL THERAPY AND CONCOMITANT NON-ANTIRETROVIRAL COMEDICATIONS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00 AM

  • PGI30 WEB-BASED RESEARCH OF QUALITY OF LIFE OUTCOME AND STATUS OF MEDICAL EXPENSE SUBSIDY FOR INTRACTABLE DISEASE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN

    May 1, 2020, 00:00 AM

  • PMH37 FACTORS INFLUENCING THE UPTAKE OF MENTAL HEALTH SERVICES IN SUB-SAHARAN AFRICA.

    May 1, 2020, 00:00 AM

  • PMS89 A REAL-WORLD STUDY OF THE PATIENT EXPERIENCE WITH ABALOPARATIDE

    May 1, 2020, 00:00 AM

  • PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES

    May 1, 2020, 00:00 AM

  • PDG52 CONCOMITANT USE OF OPIOIDS AND CENTRAL NERVOUS SYSTEM DEPRESSANTS IN PATIENTS WITH NONMALIGNANT CHRONIC PAIN AND ADHERENCE TO FOOD AND DRUG ADMINISTRATION WARNING

    May 1, 2020, 00:00 AM

  • PMU32 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A CHINESE ANALYSIS

    May 1, 2020, 00:00 AM

  • PCN13 FACTORS THAT MODIFY THE EFFECT OF MONO- OR COMBINATION PD-1/PD-L1 INHIBITOR THERAPIES ON SURVIVAL OUTCOMES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PMD46 RETROSPECTIVE ANALYSIS OF OXIDIZED ZIRCONIUM BEARING SURFACE AND MORTALITY IN HIP AND KNEE REPLACEMENT 180-DAY EPISODE CLAIMS

    May 1, 2020, 00:00 AM

  • PBI35 HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL GENE THERAPIES: THE ROAD TO REIMBURSEMENT

    May 1, 2020, 00:00 AM

  • Multiple Diseases - Clinical Outcomes

    May 1, 2020, 00:00 AM

  • PMU41 PREVALENCE AND ASSOCIATED FACTORS TO SUICIDE ATTEMPTS IN LOW-INCOME ADOLESCENTS FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • PGI4 RETROSPECTIVE STUDY OF DOSE ESCALATION WITH ADALIMUMAB, INFLIXIMAB, AND VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

    May 1, 2020, 00:00 AM

  • PMU14 THE USE OF PERSPECTIVE AND COSTING APPROACHES IN COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00 AM

  • PDG26 THE ASSOCIATION OF BETA-BLOCKERS USE TO CHRONIC PAIN AMONG ADULTS WITH CARDIOVASCULAR DISEASES (CVD) OR HYPERTENSION IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • Cost-Effectiveness Studies

    May 1, 2020, 00:00 AM

  • PIN89 REGIMEN DURABILITY AMONG HEAVILY TREATMENT-EXPERIENCED (HTE) COMPARED TO NON-HTE TREATMENT-EXPERIENCED HIV PATIENTS IN THE OPERA COHORT

    May 1, 2020, 00:00 AM

  • PMD25 EVALUATING BUDGET IMPACT OF PERIPROSTHETIC JOINT INFECTION DIAGNOSIS PATHWAYS IN TOTAL HIP AND KNEE ARTHROPLASTY PATIENTS

    May 1, 2020, 00:00 AM

  • PMS3 LORECEVIVINT, A POTENTIAL DISEASE-MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS: FACTORS DRIVING WOMAC PAIN SUBSCORE CHANGES - A POST HOC ANALYSIS OF PHASE 2B DATA

    May 1, 2020, 00:00 AM

  • Musculoskeletal Disorders - Health Policy Regulatory

    May 1, 2020, 00:00 AM

  • Mental Health - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • PIN38 COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF LIPOHYPERTROPHY IN THE US

    May 1, 2020, 00:00 AM

  • PBI20 COMPARISON OF DECISION MODELING APPROACHES FOR HEALTH TECHNOLOGY AND POLICY EVALUATION

    May 1, 2020, 00:00 AM

  • PCN9 TARGETED LITERATURE REVIEW (TLR) OF THE REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG MCRPC PATIENTS IN THE US

    May 1, 2020, 00:00 AM

  • PIN55 ASSOCIATION OF GEOGRAPHIC FACTORS AND SOCIAL DETERMINANTS WITH HERPES ZOSTER VACCINATION

    May 1, 2020, 00:00 AM

  • PIH18 POLYPHARMACY, HEALTHCARE EXPENDITURES AND HEALTH STATUS AMONG OLDER ADULTS WITH CARDIAC DISEASE

    May 1, 2020, 00:00 AM

  • PIH27 DIAGNOSING NEWBORNS WITH SUSPECTED SEVERE MITOCHONDRIAL DISORDERS: A COST-EFFECTIVENESS STUDY COMPARING EARLY WHOLE EXOME SEQUENCING TO STANDARD OF CARE

    May 1, 2020, 00:00 AM

  • PMS6 EFFECTIVENESS AND ACCEPTABILITY OF AMITRIPTYLINE AND FOOD AND DRUG ADMINISTRATION-APPROVED TREATMENTS FOR FIBROMYALGIA: A NETWORK META-ANALYSIS

    May 1, 2020, 00:00 AM

  • PMS20 COST EFFECTIVENESS OF VIRTUAL REALITY GAME VERSUS CLINIC BASED MCKENZIE EXTENSION THERAPY FOR CHRONIC NON SPECIFIC LOW BACK PAIN

    May 1, 2020, 00:00 AM

  • PDB59 THE IMPACT OF HYPERKALAEMIA AND ITS CONCURRENCE WITH CARDIORENAL COMORBIDITIES ON HEALTHCARE RESOURCE USE IN THE UK

    May 1, 2020, 00:00 AM

  • PIH82 PREVALENCE AND PREDICTORS OF POLYPHARMACY AND POTENTIALLY INAPPROPRIATE MEDICATIONS IN A LARGE COMMUNITY-DWELLING OLDER POPULATION IN ITALY

    May 1, 2020, 00:00 AM

  • PDB97 DISEASE STATE AWARENESS AND ITS IMPACT ON DISEASE MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES IN QUETTA, PAKISTAN.

    May 1, 2020, 00:00 AM

  • PGI26 THE COST-EFFECTIVENESS OF PHARMACOLOGIC VS SURGICAL INTERVENTION FOR PATIENTS HOSPITALIZED WITH ACUTE SEVERE ULCERATIVE COLITIS IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00 AM

  • PMS34 TALTZ® (IXEKIZUMAB) FOR TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES: A BUDGET IMPACT ANALYSIS

    May 1, 2020, 00:00 AM

  • PMH13 ANALYZING TRENDS IN MEDICAL EXPENDITURES ASSOCIATED WITH ALZHEIMER'S DISEASE AMONG U.S. ADULTS WITH DIABETES: 2013-2017

    May 1, 2020, 00:00 AM

  • PMU44 PREVALENCE OF MULTIMORBIDITY AMONG ASIAN INDIANS, CHINESE, AND NON-HISPANIC WHITES IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PIN79 VACCINATION COVERAGE RATE: WHAT CAN WE EXPECT FROM BRAZIL?

    May 1, 2020, 00:00 AM

  • PIN73 KNOWLEDGE OF TUBERCULOSIS AMONG PATENT AND PROPRIETARY MEDICINE VENDORS IN RURAL AREAS OF ENUGU STATE IN SOUTHEAST NIGERIA

    May 1, 2020, 00:00 AM

  • PDB53 TRENDS IN PRICES OF INSULIN MARKETED IN THE US (1984-2020)

    May 1, 2020, 00:00 AM

  • PIH38 MEASURING A RISK OF AND FACTORS ASSOCIATED WITH IN-HOME TOBACCO SMOKE EXPOSURE IN A US PEDIATRIC SAMPLE: HOUSEHOLD ECONOMICS AND VOLATILE ORGANIC COMPOUND METABOLITE DETECTION

    May 1, 2020, 00:00 AM

  • PDB35 A COST MINIMIZATION ANALYSIS OF NEGATIVE PRESSURE WOUND THERAPY TECHNOLOGIES FOR THE TREATMENT OF MODERATE TO SEVERE FOOT INFECTIONS

    May 1, 2020, 00:00 AM

  • PMU16 IN-HOSPITAL OUTCOMES ASSOCIATED WITH HEART FAILURE AMONG WOMEN WITH BREAST CANCER IN THE U.S.: AN ANALYSIS OF THE 2012-2016 NATIONAL INPATIENT SAMPLE

    May 1, 2020, 00:00 AM

  • PMH33 VARIATION IN TREATMENT PERSISTENCE BETWEEN ACUTE AND CHRONIC OPIOID USERS RECEIVING BUPRENORPHINE PRODUCTS FOR OPIOID USE DISORDER

    May 1, 2020, 00:00 AM

  • PDB28 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES PREVENTION PROGRAM (DPP) USING QUALITY OF WELL BEING (QWB) AND SF-6D INSTRUMENTS IN SAME SAMPLE: COMPLETE CASE ANALYSIS

    May 1, 2020, 00:00 AM

  • PCV88 THE APPLICATION OF BAYESIAN HETEROGENEITY TREATMENT EFFECT ANALYSIS FOR ASSESSING VARIATION AND RELIABILITY OF CONGESTIVE HEART FAILURE OUTCOMES IN A LINKED EMR-CLAIMS DATASET

    May 1, 2020, 00:00 AM

  • PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA

    May 1, 2020, 00:00 AM

  • PMU56 IMPACT OF FDA APPROVAL OF NEW AGENTS ON THERAPEUTIC OPTIONS FOR GENETIC VARIANTS IN PEDIATRIC TUMORS

    May 1, 2020, 00:00 AM

  • PIN21 ESTABLISH A PHARMACEUTICAL CARE MODE FOR THERAPEUTIC DRUG MONITORING OF VANCOMYCIN AND EVALUATE ITS EFFECTIVENESS AND ECONOMICS

    May 1, 2020, 00:00 AM

  • Injury Public Health

    May 1, 2020, 00:00 AM

  • PCV89 ASSESSMENT OF CARE OPPORTUNITY GAPS FOR ATRIAL FIBRILLATION IN NHS ENGLAND

    May 1, 2020, 00:00 AM

  • PDB40 COST-EFFECTIVENESS ANALYSIS OF SENSOR-AUGMENTED PUMP IN TYPE 1 DIABETES MELLITUS COMPARED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE RUSSIAN FEDERATION

    May 1, 2020, 00:00 AM

  • PIH70 FORMATIVE RESEARCH TO DEVELOP A CLINICAL TRIAL DECISION AID THAT INTEGRATES QUANTITATIVE PATIENT PREFERENCE DATA

    May 1, 2020, 00:00 AM

  • PMU15 RETROSPECTIVE STUDY EXAMINING HEALTH CARE UTILIZATION AND COSTS FOR PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS IN THE US

    May 1, 2020, 00:00 AM

  • PIH67 EVALUATING THE BURDEN OF ILLNESS OF PEDIATRIC PLATINUM-INDUCED HEARING LOSS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00 AM

  • PMS45 CLINICAL CHARACTERISTICS AND HEALTH OUTCOMES IN A GROUP OF ELDERLY PATIENTS WITH HIP FRACTURE IN MANIZALES, COLOMBIA.

    May 1, 2020, 00:00 AM

  • PDB50 ANNUAL HEALTH INSURANCE TREATMENT COST OF DIABETIC POLYNEUROPATHY BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00 AM

  • PMS30 ANNUAL HEALTH INSURANCE TREATMENT COST OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00 AM

  • Alternative Medicine Information Systems

    May 1, 2020, 00:00 AM

  • PMD10 A BUDGET IMPACT AND RETURN ON INVESTMENT ANALYSIS OF INCORPORATING DRUG – ELUTING STENTS INTO A CHINESE HOSPITAL MEDICAL DEVICE FORMULARY — A HOSPITAL PERSPECTIVE

    May 1, 2020, 00:00 AM

  • PMH11 LONG-TERM MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER IN THE UNITED STATES: A COST-UTILITY ANALYSIS

    May 1, 2020, 00:00 AM

  • PDB111 A COMPARATIVE EFFECTIVENESS RESEARCH STUDY OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL AND A CRYOPRESERVED CADAVERIC SKIN ALLOGRAFT FOR USE IN DIABETIC FOOT ULCERS - A NON-INFERIORITY ANALYSIS

    May 1, 2020, 00:00 AM

  • PDG9 PREVALENCE OF POLYMEDICATION IN POOR POPULATION OF THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • PMU5 PREVALENCE AND ASSOCIATED FACTORS TO PSYCHOTIC SUBSTANCE USE IN LOW-INCOME ADOLESCENTS FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00 AM

  • PGI35 REAL-WORLD MEDICATION USE AND COST OF ILLNESS IN IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN THE CHINESE SETTING

    May 1, 2020, 00:00 AM

  • Cardiovascular Disorders - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • PIN4 IMPACT OF ADHERENCE ON VIRAL SUPPRESSION IN PATIENTS WITH HIV RECEIVING BICTEGRAVIR OR DOLUTEGRAVIR REGIMENS

    May 1, 2020, 00:00 AM

  • Mental Health - Real World Data Information Systems

    May 1, 2020, 00:00 AM

  • PIN69 NOW OR LATER: THE COST BURDEN OF HCV INFECTION VS. TREATMENT FOR MEDICARE AND MEDICAID POPULATIONS

    May 1, 2020, 00:00 AM

  • PDB83 THE ROLE OF HEALTH CARE PROVIDER'S ADVICE IN PREDIABETES MANAGEMENT IN THE US

    May 1, 2020, 00:00 AM

  • PDB92 GETTING THE MOST OUT OF LATENT-CLASS ANALYSIS IN MODELING PREFERENCES FOR AN INTERCEPTION TREATMENT IN TYPE 1 DIABETES

    May 1, 2020, 00:00 AM

  • PDG32 GAME-THEORETICAL ANALYSIS OF NETFLIX PAYMENT MODEL FOR HEPATITIS C TREATMENT

    May 1, 2020, 00:00 AM

  • PMU6 EFFECTIVENESS OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL (PHMB) FOR THE TREATMENT OF CUTANEOUS WOUNDS IN A REAL WORLD SETTING

    May 1, 2020, 00:00 AM

  • PCV65 HOSPITALIZATIONS AND MORTALITY AMONG CARDIAC AMYLOIDOSIS PATIENTS COVERED BY MEDICARE ADVANTAGE

    May 1, 2020, 00:00 AM

  • PMU33 THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES

    May 1, 2020, 00:00 AM

  • PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).

    May 1, 2020, 00:00 AM

  • Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions

    May 1, 2020, 00:00 AM

  • PAM2 ORAL NUTRITIONAL SUPPLEMENTATION CAN IMPROVE POSTOPERATIVE OUTCOMES FOR COLORECTAL SURGERY PATIENTS

    May 1, 2020, 00:00 AM

  • PCV79 GENDER DISPARITY IN THE INITIATION AND COMPLIANCE FOR STATIN THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD)

    May 1, 2020, 00:00 AM

  • Musculoskeletal Disorders - Health Technology Assessment

    May 1, 2020, 00:00 AM

  • PDG49 DETERMINANTS OF NON-PHARMACOLOGIC THERAPY, OPIOID, NON-OPIOID/OPIOID COMBINATION, AND NON-OPIOID MEDICATIONS IN OUTPATIENTS WITH NONMALIGNANT CHRONIC PAIN USING RECENT NATIONAL SURVEY

    May 1, 2020, 00:00 AM

  • PMS21 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE ELBOW AND FOREARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00 AM

  • PB3 DISCORDANCE BETWEEN PSYCHIATRISTS AND THEIR PATIENTS ON DISEASE SEVERITY AND TREATMENT OUTCOMES IN SCHIZOPHRENIA

    May 1, 2020, 00:00 AM

  • PMU58 SMART SPENDING: REALLOCATING AMERICANS’ FOOD BUDGETS TO SAVE COSTS AND IMPROVE DIET QUALITY

    May 1, 2020, 00:00 AM

  • Patient Behavior Studies

    May 1, 2020, 00:00 AM

  • PMH31 RISK OF FALLS AND FRACTURES ASSOCIATED WITH CONCOMITANT USE OF ACETYLCHOLINESTERASE INHIBITORS AND ATYPICAL ANTIPSYCHOTICS AMONG OLDER ADULTS WITH DEMENTIA

    May 1, 2020, 00:00 AM

  • PMD17 ANALYSIS OF THE COST-EFFECTIVENESS OF ENDOVASCULAR AORTIC REPAIR WITH OFF-THE-SHELF ENDOGRAFTS AS ALTERNATIVE TO CUSTOM-MADE ENDOGRAFTS IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00 AM

  • PMS55 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE KNEE AND LOWER LEG BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00 AM

  • Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the ISPOR Personalized Precision Medicine Special Interest Group [Editor's Choice]

    May 1, 2020, 00:00 AM

  • Injury Information Systems

    May 1, 2020, 00:00 AM

  • PBI23 DEPRESSION AND OBESITY DIFFERENCES AMONG PSORIASIS PATIENTS BY BIOLOGICS TREATMENT

    May 1, 2020, 00:00 AM

  • Gastrointestinal Disorders - Economic Evaluation

    May 1, 2020, 00:00 AM

  • PMU59 GLOBAL OUTCOMES-BASED CONTRACTING TRENDS IN THE US AND EUROPE OVER THE PAST 5 YEARS

    May 1, 2020, 00:00 AM

  • PCN4 ACCURACY OF LIFE YEAR GAIN PREDICTIONS FOR NIVOLUMAB MONOTHERAPY IN THE LONG TERM: AN ANALYSIS ACROSS FOUR INDICATIONS

    May 1, 2020, 00:00 AM

  • PMH15 THE CHANGES OF DEPRESSION COSTS AFTER AN INTERNET-DELIVERED COGNITIVE BEHAVIOUR THERAPIES (IDCBT) PRELIMINARY DATA FROM RWD ECONOMIC MODEL

    May 1, 2020, 00:00 AM

  • PIN15 BUDGETARY IMPACT ANALYSIS OF SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL

    May 1, 2020, 00:00 AM

  • The EQ-5D-5L Value Set for England: Response to the “Quality Assurance”

    May 1, 2020, 00:00 AM

  • AI4 CAN WE DECREASE THE SCREENING BURDEN IN SYSTEMATIC REVIEWS? PERFORMANCE OF TWO NATURAL LANGUAGE PROCESSORS TO EXCLUDE RECORDS

    May 1, 2020, 00:00 AM

  • PDG75 PREVALENCE AND FACTORS ASSOCIATED WITH ANTIEPILEPTIC DRUG USE IN NURSING HOME RESIDENTS WITH PAIN

    May 1, 2020, 00:00 AM

  • PIN13 ESTIMATING THE IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN ALL HPV 6/11/16/18 -RELATED DISEASES IN COLOMBIA

    May 1, 2020, 00:00 AM

  • PMS82 PHYSICAL PARAMETERS AND THE FUNCTIONAL STATE OF THE SPINE IN AMATEUR TENNIS PLAYERS

    May 1, 2020, 00:00 AM
  • «
  • 31
  • 32
  • 33
  • 34
  • 35 (current)
  • 36
  • 37
  • 38
  • 39
  • 40
  • »